UCL Engineering announced today that two members of staff will receive funding through Grand Challenges Explorations, an initiative created by the Bill & Melinda Gates Foundation that enables individuals worldwide to test unorthodox ideas that address persistent health and development challenges. Tarit Mukhopadhyay and Professor Clare Elwell will pursue their innovative global health research projects, titled ’Elimination of the Cold Chain with Low-Cost Liquid Viral Vaccines’ and ’Novel Biomarkers of Nutrition Related Cognitive Development’. Grand Challenges Explorations funds scientists, researchers and entrepreneurs worldwide to explore ideas that can break the mold in how we solve persistent global health and development challenges. Mukhopadhyay’s and Professor Elwell’s projects are two of over 100 Grand Challenges Explorations Round 8 grants announced today by the Bill & Melinda Gates Foundation.
"Grand Challenges Explorations encourages individuals worldwide to expand the pipeline of ideas where creative, unorthodox thinking is most urgently needed," said Chris Wilson, director of Global Health Discovery and Translational Sciences at the Bill & Melinda Gates Foundation. "We’re excited to provide additional funding for select grantees so that they can continue to advance their idea towards global impact."
Grand Challenges Explorations encourages individuals worldwide to expand the pipeline of ideas where creative, unorthodox thinking is most urgently needed
Chris Wilson (Bill & Melinda Gates Foundation)
Applications for the current open round, Grand Challenges Explorations Round 9, will be accepted through May 15, 2012.
Mukhopadhyay (UCL Biochemical Engineering) and his collaborator Stephen Ward (Stabilitech Ltd.) are receiving funding to couple UCL’s vaccine bioprocess development platform with a novel Stabilitech technology to create thermo-stable viral vaccines. Most of the world’s vaccines are centrally manufactured and are refrigerated in the cold chain during delivery and storage before use. However, the cold chain frequently fails, meaning that millions of doses of vaccines are wasted each year.